CrossChannel offers independent, evidence-based insights into key developments in respiratory medicine.

Each review is designed to distil complex data and emerging research into clear, accessible analysis for clinicians, researchers, and healthcare decision-makers. Topics range from clinical guidelines and treatment innovations to environmental and policy factors affecting respiratory health.

We provide:

State-of-the-art reviews on evolving standards of care in asthma, COPD, lung cancer, and interstitial lung diseases

Therapeutic landscape updates, highlighting advances in diagnostics, pharmacological treatments, and non-drug interventions

Comparative analyses of clinical trial outcomes and real-world data

Patient-centred protocols supporting evidence-informed practice

Health systems commentary on access, equity and implementation

Unlike commissioned research, our reports, reviews and analyses are  developed independently, allowing us to present impartial perspectives grounded in critical appraisal and expert synthesis. Whether you are a practitioner seeking clinical context or a policymaker requiring an overview of current trends, these reports provide timely, reliable insight into the lung health challenges shaping today’s medical landscape.
 

Upcoming review: Central Sleep Apnoea